SEC Company Response from PDS Biotechnology Corp (PDSB) (CIK 0001472091) (PDSB) — Jan 31, 2020

PDS Biotechnology Corp (PDSB) (CIK 0001472091)
Date: Jan. 31, 2020 · CIK: 0001472091 · Accession: 0001140361-20-001974

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-235549

Date

January 31, 2020

Author

Assistant Director

Form

CORRESP

Company

PDS Biotechnology Corp (PDSB) (CIK 0001472091)

Letter

PDS Biotechnology Corporation

303A College Road East

Princeton, New Jersey 08540

January 31, 2020

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549-4561

Attention:

Suzanne Hayes

Assistant Director

Re: PDS Biotechnology Corporation

Registration Statement on Form S-1

File No. 333-235549

Ladies and Gentleman:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, PDS Biotechnology Corporation hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-235549) (the “Registration Statement”), so that the Registration Statement may become effective at 5:00 p.m. (Washington, D.C. time) on February 4, 2020 or as soon as practicable thereafter.

PDS BIOTECHNOLOGY CORPORATION

By: /s/ Frank Bedu-Addo, Ph.D.

Name: Frank Bedu-Addo, Ph.D.

Title: President and Chief Executive Officer

Show Raw Text

CORRESP
1
filename1.htm

    PDS Biotechnology Corporation

    303A College Road East

    Princeton, New Jersey 08540

    January 31, 2020

    VIA EDGAR

    Securities and Exchange Commission

    Division of Corporation Finance

    100 F Street, N.E.

    Washington, DC 20549-4561

            Attention:

            Suzanne Hayes

            Assistant Director

    Re: PDS Biotechnology Corporation

    Registration Statement on Form S-1

    File No. 333-235549

    Ladies and Gentleman:

    Pursuant to Rule 461 under the Securities Act of 1933, as amended, PDS Biotechnology Corporation hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No.
      333-235549) (the “Registration Statement”), so that the Registration Statement may become effective at 5:00 p.m. (Washington, D.C. time) on February 4, 2020 or as soon as practicable thereafter.

            PDS BIOTECHNOLOGY CORPORATION

            By:  /s/ Frank Bedu-Addo, Ph.D.

            Name: Frank Bedu-Addo, Ph.D.

            Title:  President and Chief Executive Officer

SecProbe.io